Epitor Therapeutics, Inc.
New York, NY
- UEI
- XVX9HJXKH1N1
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 4 E 70th St #9a, New York, NY 10021, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Application of a novel dcasnano-based epigenetic editing to treat rett syndrome - abstract rett syndrome is a… | National Institute of Neurological Disorders and Stroke | $698,459 |
Quick answers
What is Epitor Therapeutics, Inc.'s UEI?
Epitor Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is XVX9HJXKH1N1.
Where is Epitor Therapeutics, Inc. located?
Epitor Therapeutics, Inc.'s physical address in SAM.gov is 4 E 70th St #9a, New York, NY 10021, USA.
Is Epitor Therapeutics, Inc. registered in SAM.gov?
Yes. Epitor Therapeutics, Inc.'s SAM.gov registration is active through August 27, 2027.
What is Epitor Therapeutics, Inc.'s most recent federal award?
Epitor Therapeutics, Inc.'s most recent federal grant award is Application of a novel dcasnano-based epigenetic editing to treat rett syndrome - abstract rett syndrome is a… (R43NS139830), from National Institute of Neurological Disorders and Stroke, on September 15, 2024.
On GovTribe
See Epitor Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors